The egg production losses can be severe (up to 16 eggs per hen) and secondary infections can cause mortality.

Flocks infected with MG are more susceptible to other diseases such as IBV, NDV, Infectious Coryza and Escherichia coli.

Vaccination: an important tool to control MG

Vectormune® FP-MG and Vectormune® FP-MG + AE were developed by CEVA Santé Animale using the most advanced molecular technology to bring to the poultry industry a novel broad-spectrum vaccine that provides efficacy, safety and convenience in the control of Mycoplasma gallisepticum, Fowl Pox and Avian Encephalomyelitis.